MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1748-717X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC) ; volume:17 ; number:1 ; day:25 ; month:1 ; year:2022 ; pages:1-10 ; date:12.2022
Radiation oncology ; 17, Heft 1 (25.1.2022), 1-10, 12.2022

Creator
Pavic, Matea
Niyazi, M.
Wilke, L.
Corradini, S.
Vornhülz, M.
Mansmann, U.
Al Tawil, A.
Fritsch, R.
Hörner-Rieber, J.
Debus, Jürgen
Guckenberger, M.
Belka, C.
Mayerle, J.
Beyer, G.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13014-022-01988-6
URN
urn:nbn:de:101:1-2022050519132755344164
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pavic, Matea
  • Niyazi, M.
  • Wilke, L.
  • Corradini, S.
  • Vornhülz, M.
  • Mansmann, U.
  • Al Tawil, A.
  • Fritsch, R.
  • Hörner-Rieber, J.
  • Debus, Jürgen
  • Guckenberger, M.
  • Belka, C.
  • Mayerle, J.
  • Beyer, G.
  • SpringerLink (Online service)

Other Objects (12)

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer

Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma

Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma

MR-guided stereotactic body radiation therapy for primary cardiac sarcomas

MR-guided stereotactic body radiation therapy for primary cardiac sarcomas

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Related objects